Island Pharmaceuticals Ltd ILA
ASX · Australia · Health Technology
AUD 0.36500.00 (0.00%)
Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Island Pharmaceuticals Ltd (ASX:ILA, OTC:ILA) has entered into a Cooperative Research and Development Agreement (CRADA) with the US Army Medical Research Institute of Infectious Diseases (USAMRIID) and The Geneva Foundation to accelerate development of its antiviral drug candidate galidesivir...
We feel now is a pretty good time to analyse Island Pharmaceuticals Limited's ( ASX:ILA ) business as it appears the...
Island Pharmaceuticals Limited ( ASX:ILA ) insiders who purchased shares in the last 12 months were richly rewarded...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.